Indian or MNC pharma companies? There are reasons to look at both: 5 pharma stocks with upside potential of up to 38%
These 9 banking sector stocks have an upside potential of more than 25% in 1 year, according to analysts
Content Writing IBM is trying to rebound after results disappointed initially. What analysts and investors are saying IBM posted a mixed but strategically important quarter: it beat headline EPS and revenue estimates, and management nudged full-year guidance…